Plasma fractionation is a process employed to purify and separate plasma into individual protein components. These fractionates are then purified, which can further be used as therapeutic medicines, known as plasma-derived therapies or plasma-derived medicinal products.

The global plasma fractionation market size is estimated to grow from USD 4.80 billion in 2024 to USD 12.7 billion by 2035, representing a CAGR of 9.2% during the forecast period till 2035.

The 82% of the plasma is fractionated for the production of plasma-derived therapies utilized to treat hematological disorders, including bleeding disorders, coagulation disorders, hemophilia, and hemostasis. This is followed by the plasma therapies used to treat immunological disorders (79%) and hepatic disorders (44%).

The majority of the firms (73%) are equipped with the capability of formulation, this is followed by companies performing fill / finish (70%) and plasma testing (36%).

In order to enhance the plasma collection and plasma fractionation capabilities, companies are actively entering into strategic partnerships- During our research, we were able to identify partnership / collaboration agreements inked by around by several players engaged in this domain during the time period, 2018-2023.

The number of partnerships inked related to plasma fractionation have increased significantly during the given time period. It is worth mentioning that the maximum number of partnerships (33%) were reported in the year 2020, followed by 24% deals inked in 2021. The rise in partnership activity can be attributed to the increasing demand for blood plasma therapies used to treat COVID-19 disease. Further, in 2023 (till June), three deals have already been inked between players engaged in this domain.

Nearly 65% of the deals signed in this domain are intercontinental agreements. Majority of these deals were signed by companies based in Europe. A similar trend was observed during the establishment of intracontinental deals, where over 15% of the agreements were signed by players based in Europe. This is followed by intracontinental agreements signed by players based in Asia-Pacific and the rest of the world.

Research Methodology

Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Plasma Fractionation Market.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. 

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/plasma-fractionation-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

+1 (415) 800 3415

[email protected]